Kenji Sagawa

Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro

Kenji Maeda, Hirotomo Nakata, Yasuhiro Koh et al. · Journal of Virology · 2004 · 221 citations · Full text

Medicine, Human Retrovirus, Immunology +13

Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5

Kenji Maeda, Kazuhisa Yoshimura, Shiro Shibayama et al. · Journal of Biological Chemistry · 2001 · 126 citations · Full text

The Protein-tyrosine Phosphatase SHP-2 Associates with Tyrosine-phosphorylated Adhesion Molecule PECAM-1 (CD31)

Kenji Sagawa, Teruaki Kimura, Mark Swieter et al. · Journal of Biological Chemistry · 1997 · 105 citations · Full text

Design, Synthesis, and Biological Evaluation of the Combinatorial Library with a New Spirodiketopiperazine Scaffold. Discovery of Novel Potent and Selective Low-Molecular-Weight CCR5 Antagonists

Hiromu Habashita, Masaya Kokubo, Shin-ichi Hamano et al. · Journal of Medicinal Chemistry · 2006 · 79 citations · Full text

Combinatorial Chemistry, Drug Target, Pharmacotherapy +18

Aggregation of the High Affinity IgE Receptor Results in the Tyrosine Phosphorylation of the Surface Adhesion Protein PECAM-1 (CD31)

Kenji Sagawa, William D. Swaim, Juan Zhang et al. · Journal of Biological Chemistry · 1997 · 56 citations · Full text